Condition

Allogeneic Hematopoietic Stem Cell Transplantation clinical trials and research

• 13Clinical trials
• 4Countries

Newest Allogeneic Hematopoietic Stem Cell Transplantation clinical trials

All recruiting trials (13)

• Long-term心理 and cognitive check after stem cell transplant for immune deficiencies

  This study tests the long-term neurocognitive and psychological functioning of 6–8 year-old children who had an allogeneic stem cell transplant for a primary immune deficiency, at least two years after the transplant.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT07766304

• Low-dose Liposomal Amphotericin B for preventing fungal infections in adults with blood cancers and prolonged neutropenia

  This study tests whether giving a daily 50 mg dose of liposomal amphotericin B can help prevent invasive fungal infections in adults with blood cancers who have prolonged low white blood cell counts.

  Recruiting Haikou Affiliated Hospital of Central South University Xiangya School of Medicine · Hainan, Hainan · NCT07763054

• Moxibustion with second-line treatment for steroid-refractory acute graft-versus-host disease after transplant

  This study will test whether adding moxibustion to standard second-line drug therapy helps people aged 14–65 with steroid-refractory gastrointestinal acute GVHD after an allogeneic stem cell transplant.

  Recruiting Phase 2 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Wuhan, Hubei · NCT07572669

• Baricitinib for persistent low platelets after stem cell transplant

  We’re testing baricitinib to see if it can help people with long-term low platelets after an allogeneic stem cell transplant who didn’t respond to other treatments.

  Recruiting Phase 1/2 Peking University People's Hospital · Beijing, Beijing Municipality · NCT07535645

• Adding venetoclax to fludarabine–melphalan conditioning for people over 50 with AML or MDS getting a donor stem cell transplant

  This tests whether adding venetoclax to standard fludarabine–melphalan conditioning helps people over 50 with AML or MDS who are having an allogeneic stem cell transplant.

  Recruiting at 18 sites Phase 3 First Affiliated Hospital of Zhejiang University · Fuzhou, Fujian and 17 other locations · NCT07396480

• Cardiovascular problems after allogeneic stem cell transplant

  This study looks at heart-related problems after allogeneic hematopoietic stem cell transplantation to see how often they occur and what factors might predict them.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT07157670

• CMV-specific immunoglobulin to prevent CMV problems in children getting allogeneic stem cell transplants

  Doctors will try giving CMV-specific immunoglobulin to children having allogeneic stem cell transplants to prevent CMV reactivation and related transplant complications.

  Recruiting University of Pisa · Trieste · NCT07013370

• Geriatric Assessment to support older patients undergoing allo-HSCT

  This study tests a multidimensional geriatric assessment to see how age, health, and disease factors relate to outcomes for older adults undergoing allogeneic stem cell transplantation.

  Recruiting Peking University People's Hospital · Beijing · NCT06946654

• Providing food assistance to patients undergoing cancer treatment

  This study is testing whether giving food bags to cancer patients who struggle with food insecurity can help improve their nutrition and treatment outcomes.

  Recruiting University of Kansas Medical Center · Stanford, California and 3 other locations · NCT06802406

• Study on outcomes of patients undergoing stem cell transplantation

  This study looks at the experiences and outcomes of patients who have had or are about to have stem cell transplants to see how their treatment and health changes over time.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality and 2 other locations · NCT06708130

• Preventing relapse in high-risk T-cell leukemia after stem cell transplant

  This study is testing if a new combination of medications can help prevent relapse in patients with high-risk T-cell leukemia after they have a stem cell transplant.

  Recruiting Phase 2 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · Shanghai · NCT06686108

• Personalized conditioning regimen for stem cell transplantation

  This study is testing a personalized treatment plan for stem cell transplants in people with blood cancers to see if adjusting the doses of certain medications can improve their outcomes.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT06028828

• Using T Cell Therapy to Treat Adenovirus Infection After Stem Cell Transplant

  This study is testing whether using special immune cells from a donor can help treat adenovirus infections in patients who have had a stem cell transplant.

  Recruiting Early Phase 1 Case Comprehensive Cancer Center · Cleveland, Ohio · NCT03378102

Related topics

Quick answers

How many Allogeneic Hematopoietic Stem Cell Transplantation clinical trials are recruiting right now?

13, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in China (7 trials), United States (3 trials), France (2 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1/2: 1, Early Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →